About CRA | Expertise | Consultants | Publications | News | Events | Offices | Careers                                                                         
Take a closer look. The European Commission launched a sector inquiry into the pharmaceutical
industry, targeting allegations that generic entry was delayed and innovation had declined. On behalf
of EFPIA, the branded manufacturers' trade association, CRA responded with two reports discussing
competition and innovation in pharmaceutical markets.
 
 
  
Loading...

Recognition

CRA International earns spot on Forbes.com list of America’s 200 Best Small Companies in 2008

For the seventh consecutive year, CRA International has been named to the Forbes.com list of America’s 200 Best Small Companies in 2008. CRA ranked #173 on the 2008 list, which was announced in October of 2008.

The list ranks companies with revenues between $5 million and $750 million, and a stock price of at least $5 as of September 29 in the ranking year. Companies are evaluated according to return on equity, and sales growth and profit growth over the past 12 months and over five years.

Charles River Associates/CRA International named to the “Globe 100” list of top performing public companies in Massachusetts
 
Charles River Associates/CRA International has been named to the “Globe 100” list of top performing public companies in Massachusetts. Based on a composite score derived from financial data for the four quarters ending December 31, 2009, CRA was ranked #66 among Massachusetts-based companies whose stock is publicly traded on NASDAQ, New York Stock Exchange, or American Stock Exchange.